Reversible inhibition of intercellular junctional communication by glycyrrhetinic acid

https://doi.org/10.1016/0006-291X(86)90522-XGet rights and content

Abstract

Intercellular gap-junctional communication was measured using metabolic co-operation in co-cultures of argininosuccinate synthetase-deficient and argininosuccinate lyase-deficient human fibroblasts. 18-α-glycyrrhetinic acid (AGA) was found to inhibit communication by more than 95% at concentrations as low as 2 uM. Concentrations up to 100 uM were not cytotoxic over a period of 2 hours. Communication inhibition was of rapid onset and was readily reversible. Communication remained continuously yet reversibly blocked in cells cultured in the presence of AGA for 20 days. The related compounds 18-β-glycyrrhetinic acid and carbenoxolone also caused communication inhibition. The effect is probably not mediated via mineralocorticoid or glucocorticoid receptors since aldosterone and glucocorticoids had no effect on communication. AGA thus has properties of a useful inhibitor in the study of intercellular junctional communication.

References (16)

  • J.S. Davidson et al.

    Exp. Cell. Res

    (1984)
  • G.M. Williams et al.

    Cancer Lett

    (1981)
  • E.L. Hertzberg et al.

    Ann. Rev. Physiol

    (1981)
  • W.R. Loewenstein

    Physiol. Rev

    (1981)
  • J.S. Davidson et al.

    Cancer Res

    (1985)
  • L.P. Yotti et al.

    Science

    (1979)
  • D.J. Fitzgerald et al.

    Cancer Res

    (1980)
  • T. Enomoto et al.
There are more references available in the full text version of this article.

Cited by (282)

  • Pharmacology of pannexin channels

    2023, Current Opinion in Pharmacology
  • Inhibitors of connexin and pannexin channels as potential therapeutics

    2017, Pharmacology and Therapeutics
    Citation Excerpt :

    Direct interaction between GA and GJs is possible when the former is inserted into the plasma membrane, thereby binding to GJs and causing a conformational alteration (Davidson & Baumgarten, 1988; Davidson, Baumgarten, & Harley, 1986). This mechanism has been suggested based on the observation of rapid onset and reversal of inhibition (Davidson et al., 1986), yet the reproducibility of this effect has been questioned (Spray, Rozental, & Srinivas, 2002). Other possibilities include changes in the Cx phosphorylation status, which lead to a reduction in Cx expression (Goldberg et al., 1996; Guan, Wilson, Schlender, & Ruch, 1996).

  • Connexin, Pannexin1: A Novel Therapeutic Target for Acute Liver Injury

    2023, Chinese Journal of Modern Applied Pharmacy
View all citing articles on Scopus
View full text